Increased abundance of ARRB1, as well as FBXO11, LYZ, RPS6KB1, and SYNGR2 have comparable oncogenic effects in hepatocellular carcinoma [87–91], and MGST1 and RPS6KB1 have noted oncogenic roles in various lung cancers [92, 93]. Here, LYZ is linked to hepatocellular carcinoma.